Skip to main content

Carcinoma In Situ clinical trials at UCSF

3 research studies open to eligible people

Carcinoma in situ is a type of cancer that has not spread beyond its original location. UCSF is conducting clinical trials to test treatments for this condition. These include a study gathering health information for younger cancer patients, a trial testing a drug for bladder cancer, and a study on a web-based physical activity program for kids and teens with cancer. UCSF hopes these trials will improve treatments and outcomes for those with carcinoma in situ.

Showing trials for
  • Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

    open to eligible people ages 18 years and up

    This study will test a drug called enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC). This study will also evaluate what the side effects are and if the drug works to treat NMIBC. A side effect is anything a drug does to your body besides treating your disease. In this study enfortumab vedotin will be put into the bladder using a catheter. A catheter is a thin tube that can be put into your bladder.

    San Francisco, California and other locations

  • Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

    open to eligible people ages 8-16

    This randomized clinical phase III trial studies how well web-based physical activity intervention works in improving long term health in children and adolescents with cancer. Regular physical activity after receiving treatment for cancer may help to maintain a healthy weight and improve energy levels and overall health.

    Oakland, California and other locations

  • Project: Every Child for Younger Patients With Cancer

    open to eligible people ages up to 25 years

    This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

    Oakland, California and other locations

Our lead scientists for Carcinoma In Situ research studies include .

Last updated: